Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00477646 · ClinicalTrials.gov registry record · NA
Helping Women Stay Up-To-Date With Cancer Screening By Using a Prevention Care Manager or Usual Care
A NA study of Breast Cancer and Colorectal Cancer, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 2,241
- Enrollment target
- 1
- Study location
NCT00477646: Completed NA study of Breast Cancer and Colorectal Cancer, sponsored by Dartmouth-Hitchcock Medical Center.
NCT00477646 is a NA study of Breast Cancer and Colorectal Cancer that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 2,241 participants, below the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00477646, a NA study of Breast Cancer and Colorectal Cancer, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,241 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Women may stay up-to-date with cancer screening if a health professional helps them overcome barriers to screening, including helping them to schedule cancer screening appointments. PURPOSE: This randomized clinical trial is studying the use of health professional-tailored telephone support compared with usual care from their personal doctor to help women overcome barriers to screening for colorectal, cervical, and breast cancer.
Primary Outcome
Comparison of women in PCM and UC arms who received colon cancer screening tests during 18 month intervention period.
Conditions Studied
Interventions
- BEHAVIORAL Prevention Care Management
Study Locations (1)
New York
- Clinical Directors Network, Incorporated - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,241 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-02 |
| Phase | NA |
What the finished NCT00477646 record still lists
NCT00477646 is an interventional study that assigns participants to a tested intervention. Its 2,241 participants enrollment target places it among the larger protocols in the corpus, below the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (20% lower).
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Prevention Care Management is the first listed.
NCT00477646 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00477646 about?
NCT00477646 is a clinical study titled "Helping Women Stay Up-To-Date With Cancer Screening By Using a Prevention Care Manager or Usual Care". RATIONALE: Women may stay up-to-date with cancer screening if a health professional helps them overcome barriers to screening, including helping them to schedule cancer screening appointments. PURPOSE: This randomized clinical trial is studying the use of health professional-tailored telephone supp...
What is the current status of trial NCT00477646?
This trial is currently completed. It is a NA study. The enrollment target is 2,241 participants. The study started on 2007-07. Estimated completion is 2011-02.
What conditions does trial NCT00477646 study?
This clinical trial studies the following conditions: Breast Cancer, Colorectal Cancer, Cervical Cancer.
What interventions are being tested in trial NCT00477646?
The interventions under investigation include: Prevention Care Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00477646?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00477646 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00477646's enrollment target sits among peer trials
2,241 63rd of 1224 higher than 1,162 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia